R-547
CAS No. 741713-40-6
R-547 ( R547 )
Catalog No. M15831 CAS No. 741713-40-6
A potent, selective and ATP-competitive CDK inhibitor with Ki of 1/3/1 nM for CDK1/2/4, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 59 | Get Quote |
|
5MG | 98 | Get Quote |
|
10MG | 142 | Get Quote |
|
25MG | 267 | Get Quote |
|
50MG | 514 | Get Quote |
|
100MG | 737 | Get Quote |
|
500MG | 1521 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameR-547
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective and ATP-competitive CDK inhibitor with Ki of 1/3/1 nM for CDK1/2/4, respectively.
-
DescriptionA potent, selective and ATP-competitive CDK inhibitor with Ki of 1/3/1 nM for CDK1/2/4, respectively; has no activity against a large panel of serine/threonine and tyrosine kinases; inhibits the growth of various human tumor cell lines (HCT116 cell line IC50=80 nM), blocks G1 and G2 phases, induces apoptosis and reduces phosphorylation of Rb; demonstrates significant in vivo efficacy in the HCT116 human colorectal tumor xenograft model in nude mice.Solid Tumors Phase 1 Discontinued
-
SynonymsR547
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK1/CyclinB; CDK2/CyclinE; CDK4/CyclinD1; PKA
-
Research AreaCancer
-
IndicationSolid Tumors
Chemical Information
-
CAS Number741713-40-6
-
Formula Weight441.45
-
Molecular FormulaC18H21F2N5O4S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(C1=CN=C(NC2CCN(S(=O)(C)=O)CC2)N=C1N)C3=C(OC)C=CC(F)=C3F
-
Chemical NameMethanone, [4-amino-2-[[1-(methylsulfonyl)-4-piperidinyl]amino]-5-pyrimidinyl](2,3-difluoro-6-methoxyphenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chu XJ, et al. J Med Chem. 2006 Nov 2;49(22):6549-60.
2. DePinto W, et al. Mol Cancer Ther. 2006 Nov;5(11):2644-58.
2. DePinto W, et al. Mol Cancer Ther. 2006 Nov;5(11):2644-58.
molnova catalog
related products
-
AT-7519 hydrochlorid...
A potent CDK2 inhibitor with IC50 of 47 nM; also inhibits CDK1/4/5 with IC50 of 190/67/18 nM and shows selectivity over some kinases (Aurora A, IR kinase, MEK, PDK1, c-Abl, IC50>10 uM).
-
Riviciclib
A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.
-
Tricin
Tricin can inhibit human cytomegalovirus (HCMV) replication by inhibiting CDK9.?Tricin inhibits the proliferation and invasion of C6 glioma cells via the upregulation of focal-adhesion-finase (FAK)-targeting microRNA-7.